Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury.
about
Histone Deacetylases Exert Class-Specific Roles in Conditioning the Brain and Heart Against Acute Ischemic InjuryTransglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS blockA transient ischemic environment induces reversible compaction of chromatinHistone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regenerationThe HDAC Inhibitor Phenylbutyrate Reverses Effects of Neonatal Ventral Hippocampal Lesion in Rats.Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury.Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhageInhibition of histone deacetylase expands the renal progenitor cell population.Modulation of acetylation: creating a pro-survival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock.Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury.Hippocampal dendritic spines modifications induced by perinatal asphyxia.The neuroprotective effect of treatment of valproic Acid in acute spinal cord injury.Inhibition of histone methyltransferases SUV39H1 and G9a leads to neuroprotection in an in vitro model of cerebral ischemia.Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage.Post-translational modification and regulation of actin.Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.Epigenetic mechanisms in cerebral ischemia.Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance.Multiple roles of HDAC inhibition in neurodegenerative conditions.Inhibition of Histone Deacetylase 3 (HDAC3) Mediates Ischemic Preconditioning and Protects Cortical Neurons against Ischemia in RatsA PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury.The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia.Transcriptome remodeling in hypoxic inflammation.Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies.Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.Role of epigenetics in Alzheimer's and Parkinson's disease.Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases.The Emerging Role of Epigenetics in Cerebral Ischemia.Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology.Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models.The emerging field of epigenetics in neurodegeneration and neuroprotection.Role of histone acetylation in the activity-dependent regulation of sulfiredoxin and sestrin 2.The protective effects of plasma gelsolin on stroke outcome in rats.Role of salt-induced kinase 1 in androgen neuroprotection against cerebral ischemiaThe effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice.Effects of perinatal asphyxia on rat striatal cytoskeleton.Trichostatin A modulates intracellular reactive oxygen species through SOD2 and FOXO1 in human bone marrow-mesenchymal stem cells.
P2860
Q26801660-A77A3F50-FF8D-4AB1-88D9-06DE58013AF8Q26824549-78A91D5F-A907-46BD-B77B-C17C3222E746Q27337175-D00F7FEC-EBF6-4B86-B4CB-F63EE2C35190Q28080593-00419506-982D-487D-A482-FA83BA28C316Q30476266-5DA828E0-89EA-47EF-8192-A3B8F1CB1625Q30524207-3F6F9C68-A1E0-43A6-9DEA-2B025B84EC65Q33693885-F89F756D-864B-4D52-A96F-FC91474BDD1BQ33753676-70CBBA67-9DA6-4C4A-AB27-AB19E6036A20Q33834281-7A69CBD8-9A5D-482A-9A3F-EFA16583F475Q34635234-19ECE92F-1F7F-42FB-A682-237969F5DD49Q35153024-447A501C-CE86-4789-A780-C2A606D328D9Q35974448-34A6244C-4168-42D0-B0DA-78DEA1BCE933Q36041142-7E1122CE-07BE-4D3B-97C5-80FF3BD5C759Q36267373-5148835A-F8A5-4626-843A-A41A5CB161C6Q36510032-C2481D66-0195-4595-8B93-E8BF6B9D2BC7Q36625586-6956A1DC-83F3-49A9-952A-B6DE2F8C94D1Q36972324-6D47D053-F309-4CDE-96CF-150641214CB0Q37150340-F43C8A96-2C38-4111-845B-647694C81FE5Q37158226-FAF23DC5-16CE-4DEC-87CA-2E183D6BCB03Q37249150-CEE301B9-9B57-48B7-AEE6-AAD29B943ED6Q37407855-B20387ED-F5A0-4AD7-93B4-BF349A491B09Q37443800-6AC65E21-D6BB-4CED-9A93-8974A12B43DCQ37629173-959DB4DA-0978-41EF-AC7F-1CF373D00626Q37637177-2435CCCD-8574-4838-B367-DBC8F072131EQ37720331-989D14E1-89D9-4ED2-9C83-CAD748FD8C3EQ37787304-D9917942-3814-4ACE-9613-07DA46614FA3Q37832963-E8A48D57-D04E-4612-A79A-3C7CE4FC6DA9Q37961788-CE5CAEE4-CF81-429F-8109-BB52569C56F7Q38085375-8C4090A4-449B-4589-9623-52B422917DA7Q38090679-098894C3-53E8-4A1F-8734-B2CC5AA2CDEBQ38740709-585907BC-8F85-42D5-942A-76D254787907Q38750023-1A90E0FF-3918-4056-A75C-C756892261F3Q39037754-AED36EDD-B4A7-4777-8B24-3B588B5ACF33Q39313679-67166D46-364C-4B54-8FD1-8E5780D10438Q39346816-FB524DC1-5470-4B19-A8D8-A7B15DDF833CQ39391174-E9743392-3B2E-4041-A04F-5A833CF22669Q41808607-43833AB8-7389-4969-B77E-4C9991F5BC07Q43139216-572BAE91-F3B7-4E49-9DFF-E84C99660053Q44888669-2730BEFB-5D03-4444-A6B2-23429C42D1C8Q46797837-6780DD3B-9013-483D-9ADA-47A2C67756C8
P2860
Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Inhibition of histone deacetyl ...... ce from ischemic brain injury.
@en
Inhibition of histone deacetyl ...... ce from ischemic brain injury.
@nl
type
label
Inhibition of histone deacetyl ...... ce from ischemic brain injury.
@en
Inhibition of histone deacetyl ...... ce from ischemic brain injury.
@nl
prefLabel
Inhibition of histone deacetyl ...... ce from ischemic brain injury.
@en
Inhibition of histone deacetyl ...... ce from ischemic brain injury.
@nl
P2093
P50
P1476
Inhibition of histone deacetyl ...... ce from ischemic brain injury.
@en
P2093
Ferah Yildirim
Karen Gertz
Klaus B Fink
Matthias Endres
P304
P356
10.1016/J.EXPNEUROL.2007.11.031
P407
P577
2007-12-23T00:00:00Z